Key statistics
As of last trade MacroGenics Inc (M55:FRA) traded at 2.91, 1.18% above its 52-week low of 2.87, set on Aug 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.91 |
---|---|
High | 2.91 |
Low | 2.91 |
Bid | 2.83 |
Offer | 2.86 |
Previous close | 2.99 |
Average volume | 2.79k |
---|---|
Shares outstanding | 62.72m |
Free float | 61.06m |
P/E (TTM) | -- |
Market cap | 205.73m USD |
EPS (TTM) | -2.19 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 07:02 BST.
More ▼
Announcements
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
- MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
- MacroGenics Provides Vobramitamab Duocarmazine Update
- MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
- MacroGenics to Participate in Upcoming Investor Conference
- MacroGenics to Participate in Upcoming Investor Conferences
- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
- MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
- MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
- MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
More ▼